Skip to main content
Erschienen in: BMC Public Health 1/2019

Open Access 01.12.2019 | Research article

The psychosocial adaptation of patients with skin disease: a scoping review

verfasst von: Xiu-jie Zhang, Ai-ping Wang, Tie-ying Shi, Jun Zhang, Hui Xu, Da-qiu Wang, Li Feng

Erschienen in: BMC Public Health | Ausgabe 1/2019

Abstract

Background

Skin disease is a global public health problem that often has physiological, psychological and social impacts. However, it is not very clear how to adapt to these impacts, especially psychosocial adaptation of patients with skin disease.

Methods

We searched EMBASE, PubMed, CINAHL and PsycINFO from 2009 to 2018. The following themes were extracted from the included articles: the concepts, related factors, and interventions for psychosocial adaptation of patients with skin disease. Two reviewers independently screened and analyzed.

Results

From 2261 initial records, 69 studies were identified and analyzed. The concept of psychosocial adaptation in patients with skin disease was referred to under an assortment of descriptions. The related factors for psychosocial adaptation in patients with skin disease included the following: demographic factors (sex, age, education level, ethnicity, BMI, sleep quality, marital status, exercise amount, family history, the use of topical treatment only, personality and history of smoking); disease-related factors (disease severity, clinical symptoms, localization and duration); psychological factors (anxiety/depression, self-esteem, body image, stigma and suicidal ideation); and social factors (social support, social interaction, sexual life, economic burden and social acceptance). Despite being limited in quantity, several studies have clarified the benefits of adjuvant care in the form of cognitive behavioral training, educational training and self-help programs, all of which have become common methods for dealing with the psychosocial impacts.

Conclusions

Based on the previous literatures, we constructed a protocol of care model for psychosocial adaptation in patients with skin disease. It not only provided the direction for developing new instruments that could assess psychosocial adaptation statue, but also a basis for helping patients adjust to changes in skin disease.
Hinweise

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12889-019-7775-0.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
PA
Psychosocial Adaptation
QOL
Quality of Life

Introduction

As the largest organ of the human body, the skin is the main barrier that resists the outside world.1 Because skin diseases are often not life-threatening, attention and funds may be invested in diseases considered more serious. However, the psychosocial and occupational impact of skin disease is frequently comparable to, if not greater than, other chronic medical conditions.2 The lifetime prevalence of skin disease was reported from European five countries, with skin disease including eczema (14.2%), atopic dermatitis (7.9%), psoriasis (5.2%) and vitiligo (1.9%).3 With the deterioration of environment and various pressures, the incidence of skin disease has increased in recent years. It has become a global public health problem.4 Many skin diseases have a chronic and repeated process, which requires us to treat the disease and help patients positive adaptation.5
Roy defines adaptation as the process and outcome whereby thinking and feeling persons as individuals or in groups use conscious awareness and choice to create human and environmental integration, including physiological, psychological and social aspects.6The British Association of Dermatologists suggested that 85% of patients with skin disease have reported that the psychosocial impacts of their disease are a major component of illness, which is a concerning statistic.7 Psychological and social analyses reveal that if the body is stimulated by stress and the external environment, the emotional state will change as an instinctive response.8 Skin disorders can significantly affect the psyche, and the psyche can significantly affect skin disorders through psycho-neuro-immuno-endocrine and behavioral mechanisms.9 And the stress is related to functional and psychological processes in skin disease patients with high levels of anxiety sensitivity.8 In response to the environmental pressures of extreme grief and fear, individuals will experience continuous tension.10 Skin diseases distort body image, which may have a negative impact on the psychosocial health and quality of life (QOL) of patients.11 A high severity of itching, pain, and scaling in psoriasis patients is related to high disease severity and low QOL and work productivity.12 The psychosocial adjustment to vitiligo is mainly affected by subjective factors.13
Therefore, it will be limited to attempts to understand the psychosocial impacts of psoriasis from the perspective of current measurements of demographic characteristics and disease severity.14 It is imperative to develop appropriate psychosocial adaptation (PA) evaluation tools for patients with skin disease.15 Various clinic models have been described to provide specialised psychodermatology care in specific settings.16 However, it is not clear the concepts, related factors and interventions of PA for patients with skin diseases. They were described by this scoping review. Based on the previous literatures, we attempted to present a protocol of care model for PA in patients with skin disease.

Methods

A scoping review can examine and clarify broader areas than a systematic review to identify gaps in the evidence, clarify key concepts, and report on the types of evidence that address and inform practices in the topic area.17 Therefore, a scoping review method was chosen to allow for the inclusion of different study designs; this type of study follows the methodology model proposed by Arksey and O’Malley to map the various concepts underpinning this research area, as well as to clarify the related factors and interventions.18 We followed the guidelines of the PRISMA-ScR19 which is included as an Additional file 1 document to this paper. We did not provide detailed critical appraisal of individual studies or meta-analyses as this is a developing area of research. The steps of the review are outlined below.

Identifying the research questions

This scoping review aimed to identify the various concepts and related factors of PA for patients with skin disease by mapping the existing literature in the field to provide a basis for developing instruments to assess the status of PA. Additionally, mapping showed a variety of interventions.

Identifying relevant studies

The search strategy was formed by the project team and consulting with information specialists (see Additional file 2). The following databases EMBASE, PubMed, CINAHL and PsycINFO were chosen and searched from 2009 to 2018 for publications with no limit on language, which covered a wide range of subjects including medicine, psychosociology and nursing. EndNote was applied to exclude duplicate records and manage inclusion literatures.

Selecting the literature

The inclusion criteria were as follows:
  • Population: Patients experiencing skin diseases diagnosed as psoriasis, atopic dermatitis, eczema, vitiligo or chronic urticaria.
  • Range of concepts: The psychosocial adaptation of patients in different skin conditions. According to previous research and team discussion, the following concepts were often used to reflect psychosocial impacts of patients with skin diseases: anxiety/depression, body image, stigma, self-esteem, social support, family function, financial costs and work. Some studies even equated the PA of patients with the QOL.
  • Context: Adult population for 18 years old or older.
All articles provided primary data on the various concepts, related factors and interventions of PA for patients with skin disease from 2009 to 2018. Single case reports and comments were excluded. Firstly, in order to avoid missing valuable literature, two researchers conducted three rounds of assessments that included reading the study titles and abstracts for the inclusion and exclusion criteria. Second, the full texts of the studies identified through screening were independently assessed for eligibility by two authors. Third, the studies were classified for mapping according to the definitions and descriptions of methods provided in the publication.17 Finally, data extraction was undertaken by one author (JBI systematic review researcher) using a structured form. The accuracy of data extracted from the included studies was checked by another author. Any disagreements were resolved by a larger team discussion.

Charting the data

A total of 69 articles were finally included in this review and were then subjected to data charting. The data charting took the following information into consideration: author(s), year of publication, country of origin, study population, sample size, methodology, concept, assessment tool, related factors and interventions of PA for patients with skin diseases.

Collating, summarizing, and reporting the literature

The various concepts of PA for patients with skin diseases were identified. The related factors in the papers reviewed were classified as demographic, physiological, psychological or social factors. The interventions were reported.

Results

The search strategy yielded 2261 potential papers. After removing duplications (n = 548) and eliminating 936 by a first pass through the titles and abstracts, the potentially relevant literature was screened in two rounds and resulted in 69 studies. The remaining studies were clustered in the following three facets: i) various concepts of PA (n = 7), ii) related factors of PA (n = 51), and iii) interventions (n = 11) (Fig. 1). The characteristics of the included literature are presented in Table 1.
Table 1
Mapping of study characteristics of all studies included in this review
Study characteristics (N = 69)
N (%)
Publication years
 2009–2013
16 (23.19)
 2014-June 2018
53 (76.81)
Country of origin
 UK
8 (11.59)
 USA
8 (11.59)
 Poland
8 (11.59)
 India
6 (8.70)
 German
5 (7.25)
 China
4 (5.80)
 Japan
4 (5.80)
 Denmark
2 (2.90)
 Korea
2 (2.90)
 Italy
2 (2.90)
 Greece
2 (2.90)
 Malaysia
2 (2.90)
 Canada
2 (2.90)
 Spain
2 (2.90)
 Singapore
2 (2.90)
 Portugal
2 (2.90)
 Sweden
2 (2.90)
 Netherlands
1 (1.45)
 Turkey
1 (1.45)
 Iran
1 (1.45)
 Finland
1 (1.45)
 Ireland
1 (1.45)
 Egypt
1 (1.45)
Study types
 Cross-sectional study
43 (62.32)
 Randomized controlled trial
5 (7.25)
 Review
5 (7.25)
 Systematic review
3 (4.35)
 Case-control study
2 (2.90)
 Prospective cross-sectional study
2 (2.90)
 Case series study
2 (2.90)
 Experimental design
2 (2.90)
 Qualitative study
2 (2.90)
 Letter
2 (2.90)
 Develop a rating scale
1 (1.45)
Study population
 Psoriasis
44 (63.77)
 Atopic dermatitis
10 (14.49)
 Vitiligo
9 (13.04)
 Eczema
3 (4.35)
 Skin disease
3 (4.35)

Various concepts of psychosocial adaptation for patients with skin disease

A clear conceptual definition of psychosocial adaptation is identified by Rodgers’ evolutionary concept analysis, and the identified attributes of PA include change, process, continuity, interaction and influence, all of which were present in the multidisciplinary literature reviewed, thus demonstrating the wide use of the concept.20, 21 In the nineteenth century, skin diseases were linked to psychosocial factors. The mechanism was proposed and clarified in subsequent decades, and multidisciplinary collaboration was crucial to promote the adaptation of patients with skin diseases.22 PA was referred to under an assortment of descriptions in skin diseases including psychosocial factor,11, 23 burden,24, 25 impact,26 morbidity,15 and aspect.27 The measurement methods used in the literature are shown in Table 2.
Table 2
Measurement methods used in the literatures
Domain
Related concept
Measurement methods (N: number of studies reporting)
psychosocial
Quality of life
Dermatology Life Quality Index (DLQI) (N = 32)
European Quality of Life-5 Dimensions (EQ-5D) (N = 7)
Short Form Health Survey (SF-36) (N = 2)
General Health Questionnaire (GHQ) (N = 1)
World Health Organization Quality of Life-BREF (N = 1)
Short form of the General Health Questionnaire (GHQ-28) (N = 1)
Short-Form 12 health status instrument (N = 1)
Eczema Quality of Life Scale (EQOLS) (N = 1)
Revised Dyadic Adjustment Scale (R-DAS) (N = 1)
Subjective Burden
Skindex-29 (N = 2)
Skindex-16 (N = 2)
Skindex-19 (N = 1)
psychological
Anxiety and depression
Hospital Anxiety and Depression Scale (HADS) (N = 13)
Beck Depression Inventory (BDI) (N = 8)
42-item Depression, Anxiety and Stress Scale (DASS-42) (N = 2)
Social Anxiety Questionnaire (SAQ) (N = 2)
Center for Epidemiologic Studies Depression Scale (CES-D) (N = 2)
Self-Rating Depression Scale (SDS)&Self-Rating Anxiety (SAS) (N = 1)
Patient Health Questionnaire Depression Scale (PHQ-9) (N = 1)
Generalized Anxiety Disorder Scale (GAD-7) (N = 1)
Arabic version of the Depression, Anxiety and Stress Scale (N = 1)
Penn State Worry Questionnaire (N = 1)
State-Trait-Anxiety Inventory (N = 1)
Body image
Body Emotions Scale (BES) (N = 2)
Appearance Schemas Inventory-Revised (ASI-R) (N = 2)
Body Image Scale (BIS) (N = 2)
Body Dysmorphic Disorder Questionnaire (BDDQ) (N = 1)
Female Genital Self-image Score (FGSIS) (N = 1)
Acceptance of Life with the Disease Scale (ALDS) (N = 1)
Perceived Health Status (PHS) (N = 1)
Multidimensional Body-Self Relations Questionnaire (MBSRQ) (N = 1)
Skin Satisfaction Questionnaire (SSQ) (N = 1)
Derriford Appearance Scale (DAS-24) (N = 1)
Self-esteem
Rosenberg Self-esteem Scale (RSES) (N = 5)
Fears of Compassion Scales (FCS) (N = 1)
Brief Fear of Negative Evaluation Scale (Brief FNE) (N = 1)
Stigmatization
Stigmatization Scale (N = 3)
Stigmatization and Psoriasis Questionnaire (SPQ) (N = 1)
Psoriasis disease stigma questionnaire (PSQ) (N = 1)
Internalized Stigma Scale (ISS) (N = 1)
Alexithymia
Toronto Alexithymia Scale (TAS) (N = 1)
social
Social support
Berlin Social Support Scales (BSSS) (N = 1)
Social support rating scale (SSS) (N = 1)
Disease-Related Social Support Scale (DRSS) (N = 1)
Multidimensional Scale of Perceived Social Support (MSPSS) (N = 1)
Social interaction
Social Readjustment Rating Scale (N = 1)
Participation Scale Questionnaire (N = 1)
Social acceptance
Marlowe–Crowne Social Desirability Scale (MC-SDS) (N = 1)
Occupational effect
Work Productivity and Activity Impairment (WPAI) (N = 4)
Work Productivity and Activity Impairment Questionnaire: Psoriasis (WPAI-PSO) (N = 1)
Work Productivity and Activity Impairment-General Health (WPAI-GH) (N = 1)
Work Limitation Questionnaire (WLQ) (N = 1)
Total work productivity impairment (TWPI) (N = 1)
Total activity impairment (TAI) (N = 1)
Economic burden
Direct costs (N = 1)
Direct Costs of AD: medications, over-the-counter costs, medical testing and procedure expenses, physician visits, out-of-pocket expenses, transportation, and childcare increased as severity of AD worsened (N = 1)
Indirect Costs of AD (productivity loss of caregivers) (N = 1)
Lost productivity (N = 1)
Physical
Disease severity
Psoriasis Area and Severity Index (PASI) (N = 16)
Psoriasis Disability Index (PDI) (N = 3)
Vitiligo area scoring index (VASI) (N = 1)
Distress Thermometer (DT) (N = 1)
Physician global assessment (PGA) (N = 1)
Severity scoring of AD (SCORAD) (N = 1)
Physicians Global Assessment (PGA) score (N = 1)
Hand eczema severity:10-point visual analogue scale (VAS) (N = 1)
Patient-Oriented Scoring Atopic Dermatitis (PO-SCORAD) index (N = 1)
Impact of chronic Skin Disease on Daily Life (ISDL) (N = 1)
Self-Administered Psoriasis Area and Severity Index (SAPASI) (N = 1)
Clinical feature
Itching/pruritus: Visual Analogue Scale (VAS) (N = 2)
Juckreiz-Kognitions-Fragebogen questionnaire (N = 1)
SCORAD index (N = 1)
Distribution and extent
Body Surface Area (BSA) (N = 6)
Body surface involvement (N = 1)
Others
Sexual life
Massachusetts General Hospital-Sexual Functioning Questionnaire (MGH-SFQ) (N = 2)
Female Sexual Function Index (FSFI) (N = 1)
International Index of Erectile Function (IIEF) (N = 1)
Stress
Psoriasis Life Stress Inventory (PLSI) (N = 1)
Stress Self-assessment Scale (N = 1)
Personality
Eysenck Personality Questionnaire (EPQ) (N = 1)
Eysenck Personality Inventory (N = 1)
Life course
Course of life questionnaire (COLQ) (N = 1)
Modified psoriasis life stress inventory (N = 1)
Loneliness
UCLA loneliness scale (UCLA-Version 3) (N = 1)
Sleep Quality
Medical Outcomes Study Sleep Scale (MOS-SS) (N = 1)
Disease control
Urticaria Control Test (UCT) (N = 1)
Knowledge
Psoriasis Knowledge Assessment Questionnaire (N = 1)
Biological Markers
CRP and cytokines IL-1β, IL-6, TNFα, and IL-17 (N = 1)
Mindfulness
Five Facet Mindfulness Questionnaire (N = 1)
Table 3 shows the related factors of PA for patients with skin disease including the demographic, disease-related, psychological and social factors.
Table 3
related factors of psychosocial adaptation in patients with skin disease
Author, year
Study population and sample size
Research topic
Demographic factors
Disease related factors
Psychological factors
Social factors
Others
Nayak et al.(2018)
Psoriasis(n = 102)
Quality of Life
 
Disease severity (−)*
 
Family income (+)*
 
Kwan et al.(2018)
Psoriasis(n = 102)
Quality of life
Age (+)*
Disease severity (−)*
Depression/Anxiety (−)*
  
Itakura et al.(2018)
Chronic urticaria, AD, psoriasis (n = 1443, 1668,435)
Quality of life
   
Work productivity (+)*
 
Lee et al.(2018)
Atopic Dermatitis (n = 677)
Quality of life
  
Depression (−)*
Suicidal ideation (−)*
 
Sleep disturbance (+)*
Bidaki et al.(2018)
Vitiligo (n = 126)
Social acceptance
Woman*
Marital status*
Lesions distribution (face and neck) *
Disease duration less than 5 years*
   
Hebert et al.(2018)
Atopic dermatitis (n = 76)
Economic burden
 
Disease serverity (+)*
Itching (+)*
 
Lost productivity
Outpatient expense
 
Norreslet et al.(2018)
Atopic dermatitis (n = 23)
Work life
   
Job choice
Change or loss of job
Disability pension
 
Lakuta et al.(2018)
Psoriasis (n = 193)
Stigmatization
Depression
Social anxiety
 
Location and extent of psoriasis*
   
Kwak et al.(2017)
Atopic dermatitis (n = 662)
Occupational characteristics
   
Work format/hours
Job classification
Employment status
 
Kwan et al.(2017)
Psoriasis (n = 102)
Quality of life
India ethnicity
Education (−)*
 
Depression (−)*
Employ status
Monthly income (+)*
 
Nazik et al.(2017)
Psoriasis (n = 92VS98)
Quality of life
 
Disease severity (−)*
Self esteem (+)*
Body image (−)*
  
Alpsoy et al.(2017)
Psoriasis (n = 1485)
Internalized stigma
Education (−)*
Family history*
Disease severity (+)*
Lesions distribution (visible parts of body) *
Disease duration (+)*
 
Income level (−)*
Quality of life (−)*
Dieris-Hirche et al.(2017)
Atopic dermatitis (n = 181)
Suicidality
Age (−)*
Disease severity (+)*
Depression/Anxiety (+)*
Family support (−)*
 
Lakuta et al.(2017)
Psoriasis (n = 148)
Depressive
Female*
Disease duration (−)*
Stigma (+)*
Social support (−)*
 
Rosinska et al.(2017)
Psoriasis (n = 54)
Depressive
Female*
 
Body image (−)*
  
Nicholas et al.(2017)
Atopic Dermatitis
depression and suicidality
Female*
Age (+)*
Disease serverity (−)*
   
Lamb et al.(2017)
Psoriasis (n = 607)
Anxiety and Depression
Female*
Asian ethnicity*
Topical treatment only*
Disease serverity (+)*
   
Lakuta et al.(2017)
Psoriasis (n = 193)
Social anxiety and depression
Female*
Disease serverity (+)*
Disease duration (+)*
   
Geale et al.(2017)
Psoriasis (n = 2674)
Quality of life
 
Disease severity (−)*
   
Lesner et al.(2017)
Psoriasis (n = 682)
Quality of life
Marital status*
Itch intensity*
Depression/Anxiety*
Suicidal ideation*
  
Kimball et al.(2016)
Psoriasis (n = 694)
Work productivity
Sleep problems*
Pruritus (−)*
   
Zhu et al.(2016)
Psoriasis (n = 108)
Stigma
   
Social support (−)*
Social interaction (−)*
Quality of life (−)*
Sarhan et al.(2016)
Vitiligo (n = 50VS25)
Quality of life
 
Lesions distribution*
  
Sexual life*
Korman et al.(2016)
Psoriasis (n = 694)
Quality of life
 
Disease severity (−)*
Scaling, itching, pain*
 
Work productivity (+)*
 
Bonotis et al.(2016)
Vitiligo (n = 216)
Quality of life
Sex*
Personality*
 
Self esteem (−)*
  
Cazzaniga et al.(2016)
Chronic hand eczema (n = 199)
Quality of life
Psychosocial adjustment
   
Job loss and change
High rate of sick leave
Intense use of health care services
Tee et al.(2016)
Psoriasis (n = 100)
Quality of life
 
Disease severity (−)*
Depression/Anxiety (−)*
  
Molina-Leyva et al.(2016)
Psoriasis (n = 79VS79)
Erectile Dysfunction
Smoking
BMI
 
Depression/Anxiety (−)*
  
Ji et al.(2016)
Psoriasis (n = 191VS191)
Erectile Dysfunction
Age*
Hypertention
Hyperlipidemia*
 
Depression*
  
Innamorati et al.(2016)
Psoriasis (n = 100VS97)
Quality of life
BMI*
 
Depression*
  
Korman et al.(2016)
Psoriasis (n = 681)
Quality of life
 
Disease severity (−)*
 
Work productivity (+)*
 
Molina-Leyva et al. (2015)
Psoriasis (n = 133)
Sexual Function
 
Distribution of lesions*
   
Ahmed et al.(2015)
hand eczema (n = 1023)
Self-esteem
     
Korman et al.(2015)
Psoriasis (n = 700)
Quality of life
 
Disease severity (−)*
Scaling, itching, pain*
 
Work productivity (+)*
 
Schmitt et al.(2015)
Psoriasis (n = 201)
Quality of life
   
Work productivity
Indirect costs
 
Ayala et al.(2014)
Psoriasis (n = 787)
Work-related problem
Sex*
Low education*
Disease serverity (+)*
Localization*
Shame*
Anger*
Self-esteem*
  
Khoury et al.(2014)
Psoriasis (n = 8)
Body image
Exercise (+)*
Body coverage (−)*
 
Social support (+)*
Sexual inhibitions (+)*
Mattila et al. (2013)
Psoriasis (n = 262)
Work
   
Change of occupation
Sick leave days
Early retirement from work
 
Yano et al. (2013)
Atopic Dermatitis (n = 112)
Work productivity and activity impairment
 
Disease serverity (+)*
  
Quality of life (+)*
Chen et al. (2013)
Psoriasis (n = 12,300VS61,500)
Sexual dysfunction
Male*
Aged*
    
Lewis-Beck et al. (2013)
Psoriasis (n = 199)
Quality of life
 
Itching intensity (−)*
Pain (−)*
Scaling (−)*
 
Work productivity (+)*
 
Chrostowska-Plak et al. (2013)
Atopic Dermatitis (n = 89)
Quality of life
 
Pruritus (−)*
Depression (−)*
  
Schneider et al. (2013)
Psoriasis (n = 50)
Social anxiety
Social avoidance
 
Disease severity (+)*
Feelings of helplessness (+)*
Social support (−)*
Quality of life (−)*
Premkumar et al. (2013)
Psoriasis (n = 300)
Quality of life
Aged*
Low education*
Disease severity (−)*
 
Stigma (−)*
 
Sampogna et al. (2012)
Psoriasis (n = 936)
Quality of life
Female*
Low education*
Disease severity (−)*
Depression/Anxiety (−)*
Shame, angry and problems in daily activities and social life
 
Janowski et al. (2012)
Psoriasis (n = 113)
Quality of life
/Adaptation
Gender*
  
Social support (+)*
 
Levy et al.(2012)
Psoriasis (n = 90)
Quality of life
   
Direct costs*
Lose productivity*
Economy burden
Chan et al. (2012)
Vitiligo (n = 145)
Depression
Age (+)*
Sex*
 
Self-esteem (+)*
  
Brito et al. (2012)
Psoriasis (n = 101patients + 78 partners)
Adjustment
  
Body image (+)*
Relationship between patients and partners
 
Pereira et al. (2012)
Psoriasis (n = 101)
Adjustment
 
Disease severity (−)*
Depression/Anxiety (−)*
Family coping in patients and their partners
 
Pichaimuthu et al. (2011)
Vitiligo and psoriasis (n = 300)
Stigma
   
Participant restrictions (+)*
 
Note: + positive correlation, −negative correlation, *p < 0.05 statistically significant

Demographic factors

With regard to demographic facets, the key factors reported were sex,13, 2838 age,31, 35, 3841 education level,34, 36, 4143 ethnicity,32, 42 BMI,44, 45 sleep quality,46, 47 marital status,28, 48 exercise amount,49 family history,43 the use of topical treatment only,32 personality13 and history of smoking.44 Females were more prone to depressive and psychosocial maladaptation than males with skin disease.28, 31, 50 Because females were more likely to believe in the importance of physical appearance to their personal or social values than males, their investment in physical attractiveness was significantly increased. Psychological impacts related to skin disease may largely be attributed to the patients’ maladaptive assumptions about appearance and society’s focus on the perfect body and beauty. However, the genital lesions in males were more prone to cause sexual dysfunction than the lesions in females.35 There was no agreement for the impact of age on psychosocial level.31 Younger psoriasis patients can experience feelings of embarrassment, disturbance of daily activities, poor physical health, and low productivity at work. Nevertheless, it was also found that old age was related to a high risk for depression in atopic dermatitis patients. Education level also influenced the QOL of patients with psoriasis.
The disease-related factors were severity,12, 3134, 36, 3941, 43, 49, 5160 clinical symptoms (itching,47, 48, 52, 61 pain, scaling),12, 54, 62 localization (visible and genital parts)28, 34, 43, 50, 63, 64 and duration.28, 29, 33, 43 The severity of the skin disease was associated with the level of depression and anxiety, and it had a negative effect on QOL.23, 27 Itching is the cardinal clinical symptom of patients with skin disease, which can result in sleep deprivation and mental disorders. However, the localization of the skin lesions was often more important than the disease severity and was associated with negative mental health, including depression, social anxiety, self-image disorder, and stigmatization. The ‘sensitive’ body regions were defined as the visible parts of the body, which included the scalp, face, neck, hand and fingernails.43 Additionally, the psoriasis lesions located on the genitals, buttocks, abdomen, chest or lumbar region were more likely to lead to sexual dysfunction.64 The clinical symptoms of psoriasis, particularly itching, pain and scaling, negatively affected health outcomes and work productivity.62

Psychological factors

With respect to psychological facet, the related factors included anxiety and depression,36, 39, 40, 42, 4446, 48, 55, 60, 61, 65 self-esteem,13, 34, 53, 66 body image,30, 53, 67 stigma29, 41 and suicidal ideation.46, 48 Skin disease patients have a high level of anxiety or depression. Proinflammatory cytokines such as IL-1 and IL-6 were found in both psoriasis and depression, indicating that the inflammatory process may be involved in the progression of both diseases.68 Depression in psoriasis patients was related to a high risk of stroke and cardiovascular death, especially during acute depression.69 The adaptation of vitiligo patients has been considered to be affected by self-esteem levels. The following five common themes of stigma have been identified in patients with psoriasis: anticipation of rejection, feelings of being flawed, sensitivity to the attitudes of society, secretiveness, guilt and shame.15 A high level of stigma and low self-esteem have negative effects on patient compliance.

Social factors

The social factors of PA in patients with skin disease were: social support,29, 37, 40, 49, 57, 70 social interaction,36, 67, 70, 71 sexual life49, 63 and economic burden 42, 7276 (medical expenses,52 work productivity,12, 52, 54, 59, 62, 77, 78 income level43, 51). It was found that high levels of perceived social support were positively correlated with the low occurrence of depressive symptoms.11 The marriages and relationships of 50% of vitiligo patients were negatively affected by skin disease.79 Due to its physical symptoms and the stigma caused by the appearance of skin, psoriasis can be considered a socially isolating disease.68 Psoriasis, a chronic inflammatory skin disease, seems to be related to erectile dysfunction, which was a predictor of future cardiovascular disease.65 It is critical to accurately evaluate effective treatments of skin disease to understand the interaction between lost productivity, direct costs and quality of life.76

Interventions of psychosocial adaptation for patients with skin disease

The outcomes of PA include positive and negative aspects.20 Table 4 shows the PA interventions of skin disease included cognitive behavioral therapy,8086 educational training,82, 8789 self-help programs,80, 81, 84 psychotherapy84 and communication.90
Table 4
Psychosocial adaptation interventions of skin disease
Author, year
Study population (sample size)
Type of Intervention
Follow up
Outcome
Rzepecki et al.(2018)
Vitiligo
Adjuvant care:
group therapy
cognitive behavioral therapy
self-help programs
  
Nagarajan et al.(2018)
Psoriasis and control,(n = 52VS52)
Video-assisted teaching program regarding psoriasis on the level of knowledge and relaxation therapy
3 months
Improving the knowledge and quality of life of patients with psoriasis.
Keyworth et al.(2018)
Psoriasis (n = 217)
Health risk communication: message framing theory
Gain-frame messages and loss-frame messages
 
Alcohol reduction: loss-framed messages appear to be more effective for cardiovascular disease risk reduction information.
Psoriasis symptom reduction: gain-framed messages are more effective.
Messages about cardiovascular disease result in higher emotional responses compared to messages about psoriasis symptom reduction.
Paul et al.(2018)
Psoriasis (n = 94)
Mindfulness-based cognitive therapy (MBCT) (n = 25)
Mindfulness-based self-compassion therapy (MBSCT) (n = 25)
Self-help MBSCT (MBSCT-SH) (n = 22)
Treatment-as-usual (TAU) (n = 22)
12 months
Improving the long-term psychological and physical outcomes of individuals with psoriasis.
Zill et al.(2018)
Psoriasis
Cognitive behavioral techniques:
Mindfulness and meditation
Emotional writing
Individual and group setting
 
Most studies reported positive but nonsignificant effects on the different patient-reported outcomes.
Heratizadeh et al.(2017)
Atopic dermatitis
intervention group (n = 168)
intervention group (n = 168)
Educational training: a comprehensive 12-h training manual
12 months
Itching (catastrophizing cognitions):Juckreiz- Kognitions -Fragebogen questionnaire
Social anxiety: Marburger Hautfragebogen questionnaire
Subjective burden by symptoms of the disease: Skindex-29 questionnaire
Improvement of disease signs and symptoms: SCORAD index
Hashimoto
et al.(2017)
Atopic dermatitis
(n = 12)
Psychological and educational interventions: The psychological interventions included supportive, cognitive, behavioral, and psychodynamic psychotherapies, cognitive-behavioral therapy, and physical training such as progressive muscle relaxation. Lectures, audiotapes, books, videotapes, and question-and-answer sessions for the educational interventions contained information on the disease, treatment options, and strategies for management and prevention.
 
The data did not have sufficient power to provide evidence-based conclusions.
Van et al.
(2016)
Psoriasis
care as usual (CAU, n = 66) (ICBT+ CAU (n = 65)
Internet-based cognitive behavioral therapy (ICBT)
6 months
Results underline the promise of therapist-guided, individually tailored ICBT to improve physical functioning and reduce the impact of psoriasis on daily activities in patients with a psychological risk profile. Establishing a good therapeutic relationship early on may be an important factor that influences treatment outcomes in personalized ICBT interventions. Further research is needed to evaluate ICBT effectiveness in additional samples and to explore its underlying mechanisms.
Jha et al.(2016)
Vitiligo (n = 13)
Behavior therapy techniques:
Psycho-education
Breathing/relaxation and imagery
Self-statements
Exposure and desensitization
3 months
The feasibility of such therapy would depend upon the willingness and ability of both the dermatologist and the patient to set aside the time required.
Interventions with less frequent sessions of shorter duration may ensure better patient compliance.
Shah et al.(2014)
Vitiligo
CBSH+(n = 24)
CBSH (n = 25)
Control (n = 26)
Cognitive behavioral self-help intervention (CBSH) had three parts:
Psycho-education, including a description of how social anxiety is likely to be maintained in vitiligo;
Symptom monitoring with an emphasis on the recognition of self-focused attention and triggers of anxiety;
Guided imagery based relaxation and techniques for switching attention.
2 months
The findings demonstrate that augmented CBSH provides a relatively simple and accessible intervention that can result in a clinically significant reduction in social anxiety. The augmented intervention has potential and might be further developed and evaluated in subsequent trials.
Bundy et al.(2013)
Psoriasis
eTIPs (n = 67)
Control (n = 68)
Electronic Cognitive behavioral therapy intervention for Psoriasis (eTIPs), 6-week programme
6 months
This first online CBT intervention for people with skin disease showed improvement in anxiety and quality of life in patients with psoriasis.

Discussion

This scoping review analyzed the contents of 69 papers with results that were three-fold: i) some reported the various concepts of PA for patients with skin disease, which required that future research should unify the terms; ii) some reported the related factors of PA for patients with skin disease, which provided a basis for developing instruments that assess the status of PA for patients with skin disease; and iii) others reported a variety of interventions, which provided a basis for formulating a protocol of care model for PA in patients with skin disease.
Patients with skin disease often have to cope with a condition that leads to physical disfigurement, psychological destruction and social stigma. Although a large number of studies have been conducted on the treatment of patients with skin diseases, few studies have been directed towards the status and interventions of the psychosocial adaptation for patients with skin disease. It was shown that psychoeducational intervention for acceptance and managing social impact is needed, which is also the first step to informing the development of a patient-centered psychological intervention.91 Adding nondrug treatments such as biofeedback, cognitive behavioral methods, CES, EFT, EMDR, hypnosis, mindfulness meditation, placebo effect, or suggestions often enhances the therapeutic effect.9 The major routes for coping with the impacts of skin disease include the doctor-patient relationship, education of the patient and the community about the actual nature of these diseases, and more structured therapeutic strategies such as individual, group, or behavioral therapy. In response to patient feedback and NICE guidelines, the ‘Psoriasis Direct’ service was launched in 2013; this service aims to give patients open access to specialist nurses when they need it for secondary care, and ‘Psoriasis Direct’ has received overwhelmingly positive feedback.92 Despite being limited in quantity, several studies have clarified the benefits of adjuvant care in the form of cognitive behavioral training, educational training and self-help programs. An electronic health record system for patients with skin disease has not been established for long-term follow-up, so there is a lack of a systematic care model and financial support.93
Most researchers have posited models in which adaptation is conceptualized as a process of change in reaction triggered by functional limitations associated with external environmental antecedents (eg, injury, accidents, traumas) or internal pathogenic condition (eg, disease).21 And the adaptation process suggests an unfolding paradigm in which the individual’s reactions to his or her chronic illness or disability follow a stable sequence of phase (ie, partially overlapping and nonexclusive psychosocial reactions), or stage (ie, discrete and categorically exclusive psychosocial reactions) that can be temporally and hierarchically ordered. Others view psychosocial adaptation to chronic illness and disability as one of a set of independent and nonsequential patterns of human behavior.21 Based on previous theories and studies, when individuals have skin diseases, the individuals will make different primary assessments due to their different demographic, psychological and social conditions. If individuals think they can cope with the skin disease, they will adopt a positive attitude and behavior to face it, which refers to positive psychosocial adaptation. However, if individuals think they cannot cope with the skin disease, they will suffer from psychosocial maladaptation or conduct a secondary assessment. The above two situations continued to occur after the secondary assessment. If we can carry out targeted psychosocial intervention before the individual experience invalid adaptation, we can help patients positively deal with the skin disease and then promote patient adaptation (Fig. 2).

Strength and limitations

This research included studies in different settings, which brought to light the range of concept and related factors of PA for patients with skin disease, which could provide the direction for further research. A scoping review method was chosen to allow for the inclusion of different study designs, and it does not involve detailed critical appraisal of individual studies or meta-analyses. Considering partial databases selected and gray literature not included, the results are used only as an overview of the field.

Conclusion

The clinical process of a series of skin diseases is the result of a complex and sometimes reciprocal interaction among biological, psychological, and social factors, all of which can play a role in the occurrence and development of skin diseases. This review described the range of concept and related factors of psychosocial adaptation for patients with skin disease, which could contribute to the development of new instruments. The protocol of care model based on previous theory and research could provide directions for care and policy that promote psychosocial adaptation for patients with skin disease. Further research is needed to examine the effectiveness of psychosocial interventions based on the protocol of care model for individuals with skin disease.

Supplementary information

Supplementary information accompanies this paper at https://​doi.​org/​10.​1186/​s12889-019-7775-0.

Acknowledgements

N/A
We strictly followed the standards of scoping review. There were no human participants and therefore no ethical approvals were not required.
Not applicable.

Competing interests

The authors declare they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Basavaraj KH, Navya MA, Rashmi R. Dermatology. USA: Elsevier; 2010. Basavaraj KH, Navya MA, Rashmi R. Dermatology. USA: Elsevier; 2010.
2.
Zurück zum Zitat Hong J, Koo B, Koo J. The psychosocial and occupational impact of chronic skin disease. Dermatol Ther. 2008;21(1):54–9.PubMedCrossRef Hong J, Koo B, Koo J. The psychosocial and occupational impact of chronic skin disease. Dermatol Ther. 2008;21(1):54–9.PubMedCrossRef
3.
Zurück zum Zitat Svensson A, Ofenloch RF, Bruze M, Naldi L, Cazzaniga S, Elsner P, Goncalo M, Schuttelaar MA, Diepgen TL. Prevalence of skin disease in a population-based sample of adults from five European countries. Br J Dermatol. 2018;178(5):1111–8.PubMedCrossRef Svensson A, Ofenloch RF, Bruze M, Naldi L, Cazzaniga S, Elsner P, Goncalo M, Schuttelaar MA, Diepgen TL. Prevalence of skin disease in a population-based sample of adults from five European countries. Br J Dermatol. 2018;178(5):1111–8.PubMedCrossRef
4.
Zurück zum Zitat GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211–59.CrossRef GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211–59.CrossRef
6.
Zurück zum Zitat Roy C. Extending the Roy adaptation model to meet changing global needs. Nurs Sci Q. 2011;24:345–51.PubMedCrossRef Roy C. Extending the Roy adaptation model to meet changing global needs. Nurs Sci Q. 2011;24:345–51.PubMedCrossRef
8.
Zurück zum Zitat Dixon LJ, Witcraft SM, McCowan NK, Brodell RT. Stress and skin disease quality of life: the moderating role of anxiety sensitivity social concerns. Br J Dermatol. 2018;178:951–7.PubMedCrossRef Dixon LJ, Witcraft SM, McCowan NK, Brodell RT. Stress and skin disease quality of life: the moderating role of anxiety sensitivity social concerns. Br J Dermatol. 2018;178:951–7.PubMedCrossRef
9.
Zurück zum Zitat Shenefelt PD. Behavioral and psychotherapeutic interventions in dermatology. The handbook of behavioral medicine, vol. Vols. 1–2: Wiley-Blackwell; 2014. p. 570–92. Shenefelt PD. Behavioral and psychotherapeutic interventions in dermatology. The handbook of behavioral medicine, vol. Vols. 1–2: Wiley-Blackwell; 2014. p. 570–92.
10.
Zurück zum Zitat Folkman S, Lazarus RS. Coping as a mediator of emotion. J Pers Soc Psychol. 1988;54:466–75.PubMedCrossRef Folkman S, Lazarus RS. Coping as a mediator of emotion. J Pers Soc Psychol. 1988;54:466–75.PubMedCrossRef
11.
Zurück zum Zitat Wojtyna E, Lakuta P, Marcinkiewicz K, Bergler-Czop B, Brzezinska-Wcislo L. Gender, body image and social support: biopsychosocial deter-minants of depression among patients with psoriasis. Acta Derm Venereol. 2017;97:91–7.PubMedCrossRef Wojtyna E, Lakuta P, Marcinkiewicz K, Bergler-Czop B, Brzezinska-Wcislo L. Gender, body image and social support: biopsychosocial deter-minants of depression among patients with psoriasis. Acta Derm Venereol. 2017;97:91–7.PubMedCrossRef
12.
Zurück zum Zitat Korman NJ, Zhao Y, Pike J, Roberts J, Sullivan E. Increased severity of itching, pain, and scaling in psoriasis patients is associated with increased disease severity, reduced quality of life, and reduced work productivity. Dermatol Online J. 2015;10:21 pii: 13030/qt1x16v3dg. Korman NJ, Zhao Y, Pike J, Roberts J, Sullivan E. Increased severity of itching, pain, and scaling in psoriasis patients is associated with increased disease severity, reduced quality of life, and reduced work productivity. Dermatol Online J. 2015;10:21 pii: 13030/qt1x16v3dg.
13.
Zurück zum Zitat Bonotis K, Pantelis K, Karaoulanis S, Katsimaglis C, Papaliaga M, Zafiriou E, et al. Investigation of factors associated with health-related quality of life and psychological distress in vitiligo. J Dtsch Dermatol Ges. 2016;14:45–9.PubMed Bonotis K, Pantelis K, Karaoulanis S, Katsimaglis C, Papaliaga M, Zafiriou E, et al. Investigation of factors associated with health-related quality of life and psychological distress in vitiligo. J Dtsch Dermatol Ges. 2016;14:45–9.PubMed
14.
Zurück zum Zitat Perrott SB, Murray AH, Lowe J, Mathieson CM. The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization. Physiol Behav. 2000;70:567–71.PubMedCrossRef Perrott SB, Murray AH, Lowe J, Mathieson CM. The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization. Physiol Behav. 2000;70:567–71.PubMedCrossRef
15.
Zurück zum Zitat Foggin E, Cuddy L, Young H. Psychosocial morbidity in skin disease. Br J Hosp Med (Lond). 2017;78:C82–6.CrossRef Foggin E, Cuddy L, Young H. Psychosocial morbidity in skin disease. Br J Hosp Med (Lond). 2017;78:C82–6.CrossRef
16.
Zurück zum Zitat Zhou S, Mukovozov I, Chan AW. What is known about the Psychodermatology clinic model of care? A systematic scoping review. J Cutan Med Surg. 2018;22(1):44–50.PubMedCrossRef Zhou S, Mukovozov I, Chan AW. What is known about the Psychodermatology clinic model of care? A systematic scoping review. J Cutan Med Surg. 2018;22(1):44–50.PubMedCrossRef
17.
Zurück zum Zitat Aromataris E, Munn Z. Joanna Briggs institute Reviewer’s manual. South Australia: The Joanna Briggs Institute; 2017. Aromataris E, Munn Z. Joanna Briggs institute Reviewer’s manual. South Australia: The Joanna Briggs Institute; 2017.
18.
Zurück zum Zitat Arksey H, O'Malley L. Scoping studies towards a methodological framework. Int J Soc Res Methodol. 2005;8:19.CrossRef Arksey H, O'Malley L. Scoping studies towards a methodological framework. Int J Soc Res Methodol. 2005;8:19.CrossRef
19.
Zurück zum Zitat Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tunçalp Ö, Straus SE. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73.CrossRefPubMed Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tunçalp Ö, Straus SE. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73.CrossRefPubMed
20.
Zurück zum Zitat Londono Y, McMillan DE. Psychosocial adaptation: an evolutionary concept analysis exploring a common multidisciplinary language. J Adv Nurs. 2015;71:2504–19.PubMedCrossRef Londono Y, McMillan DE. Psychosocial adaptation: an evolutionary concept analysis exploring a common multidisciplinary language. J Adv Nurs. 2015;71:2504–19.PubMedCrossRef
21.
Zurück zum Zitat Livneh H, RF A. Psychosocial adaptation to chronic illness and disability: Marylan d:Aspen publishers; 1997. Livneh H, RF A. Psychosocial adaptation to chronic illness and disability: Marylan d:Aspen publishers; 1997.
22.
Zurück zum Zitat Chouliara Z, Stephen K, Buchanan P. The importance of psychosocial assessment in dermatology: opening Pandora’s box? Dermatol Nurs. 2017;16(4):30–4. Chouliara Z, Stephen K, Buchanan P. The importance of psychosocial assessment in dermatology: opening Pandora’s box? Dermatol Nurs. 2017;16(4):30–4.
23.
Zurück zum Zitat Li L, Liu P, Li J, Xie HF, Kuang YH, Li J, et al. Psychosocial factors of chronic hand eczema. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017;42:179–83.PubMed Li L, Liu P, Li J, Xie HF, Kuang YH, Li J, et al. Psychosocial factors of chronic hand eczema. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017;42:179–83.PubMed
24.
Zurück zum Zitat Marron SE, Tomas-Aragones L, Navarro-Lopez J, Gieler U, Kupfer J, Dalgard FJ, et al. The psychosocial burden of hand eczema: data from a European dermatological multicentre study. Contact Dermatitis. 2018;78:406–12.PubMedCrossRef Marron SE, Tomas-Aragones L, Navarro-Lopez J, Gieler U, Kupfer J, Dalgard FJ, et al. The psychosocial burden of hand eczema: data from a European dermatological multicentre study. Contact Dermatitis. 2018;78:406–12.PubMedCrossRef
25.
Zurück zum Zitat Krishna GS, Ramam M, Mehta M, Sreenivas V, Sharma VK, Khandpur S. Vitiligo impact scale: an instrument to assess the psychosocial burden of vitiligo. Indian J Dermatol Venereol Leprol. 2013;79:205–10.PubMedCrossRef Krishna GS, Ramam M, Mehta M, Sreenivas V, Sharma VK, Khandpur S. Vitiligo impact scale: an instrument to assess the psychosocial burden of vitiligo. Indian J Dermatol Venereol Leprol. 2013;79:205–10.PubMedCrossRef
26.
Zurück zum Zitat Richards HL. The psychosocial impact of psoriasis: implications for treatment, ProQuest Information & Learning; 2018. Richards HL. The psychosocial impact of psoriasis: implications for treatment, ProQuest Information & Learning; 2018.
27.
Zurück zum Zitat Kouris A, Christodoulou C, Stefanaki C, Livaditis M, Tsatovidou R, Kouskoukis C, et al. Quality of life and psychosocial aspects in Greek patients with psoriasis: a cross-sectional study. An Bras Dermatol. 2015;90:841–5.PubMedPubMedCentralCrossRef Kouris A, Christodoulou C, Stefanaki C, Livaditis M, Tsatovidou R, Kouskoukis C, et al. Quality of life and psychosocial aspects in Greek patients with psoriasis: a cross-sectional study. An Bras Dermatol. 2015;90:841–5.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Bidaki R, Majidi N, Moghadam Ahmadi A, Bakhshi H, Sadr Mohammadi R, Mostafavi SA, et al. Vitiligo and social acceptance. Clin Cosmet Investig Dermatol. 2018;11:383–6.PubMedPubMedCentralCrossRef Bidaki R, Majidi N, Moghadam Ahmadi A, Bakhshi H, Sadr Mohammadi R, Mostafavi SA, et al. Vitiligo and social acceptance. Clin Cosmet Investig Dermatol. 2018;11:383–6.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Lakuta P, Marcinkiewicz K, Bergler-Czop B, Brzezinska-Wcislo L. How does stigma affect people with psoriasis? Postepy Dermatol Alergol. 2017;34:36–41.PubMedPubMedCentralCrossRef Lakuta P, Marcinkiewicz K, Bergler-Czop B, Brzezinska-Wcislo L. How does stigma affect people with psoriasis? Postepy Dermatol Alergol. 2017;34:36–41.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Rosinska M, Rzepa T, Szramka-Pawlak B, Zaba R. Body image and depressive symptoms in person suffering from psoriasis. Psychiatr Pol. 2017;51:1145–52.PubMedCrossRef Rosinska M, Rzepa T, Szramka-Pawlak B, Zaba R. Body image and depressive symptoms in person suffering from psoriasis. Psychiatr Pol. 2017;51:1145–52.PubMedCrossRef
31.
Zurück zum Zitat Nicholas MN, Gooderham MJ. Atopic dermatitis, depression, and Suicidality. J Cutan Med Surg. 2017;21:237–42.PubMedCrossRef Nicholas MN, Gooderham MJ. Atopic dermatitis, depression, and Suicidality. J Cutan Med Surg. 2017;21:237–42.PubMedCrossRef
32.
Zurück zum Zitat Lamb RC, Matcham F, Turner MA, et al. Screening for anxiety and depression in people with psoriasis: a cross-sectional study in a tertiary referral setting. Br J Dermatol. 2017;176(4):1028–34.PubMedCrossRef Lamb RC, Matcham F, Turner MA, et al. Screening for anxiety and depression in people with psoriasis: a cross-sectional study in a tertiary referral setting. Br J Dermatol. 2017;176(4):1028–34.PubMedCrossRef
33.
Zurück zum Zitat Lakuta P, Przybyla-Basista H. Toward a better understanding of social anxiety and depression in psoriasis patients: the role of determinants, mediators, and moderators. J Psychosom Res. 2017;94:32–8.PubMedCrossRef Lakuta P, Przybyla-Basista H. Toward a better understanding of social anxiety and depression in psoriasis patients: the role of determinants, mediators, and moderators. J Psychosom Res. 2017;94:32–8.PubMedCrossRef
34.
Zurück zum Zitat Ayala F, Sampogna F, Romano GV, Merolla R, Guida G, Gualberti G, et al. The impact of psoriasis on work-related problems: a multicenter cross-sectional survey. J Eur Acad Dermatol Venereol. 2014;28:1623–32.PubMedCrossRef Ayala F, Sampogna F, Romano GV, Merolla R, Guida G, Gualberti G, et al. The impact of psoriasis on work-related problems: a multicenter cross-sectional survey. J Eur Acad Dermatol Venereol. 2014;28:1623–32.PubMedCrossRef
35.
Zurück zum Zitat Chen YJ, Chen CC, Lin MW, Chen TJ, Li CY, Hwang CY, et al. Increased risk of sexual dysfunction in male patients with psoriasis: A nationwide population- based follow- up study. J Sex Med. 2013;10:1212–8.PubMedCrossRef Chen YJ, Chen CC, Lin MW, Chen TJ, Li CY, Hwang CY, et al. Increased risk of sexual dysfunction in male patients with psoriasis: A nationwide population- based follow- up study. J Sex Med. 2013;10:1212–8.PubMedCrossRef
36.
Zurück zum Zitat Sampogna F, Tabolli S, Abeni D. Living with psoriasis: prevalence of shame, anger, worry, and problems in daily activities and social life. Acta Derm Venereol. 2012;92:299–303.PubMedCrossRef Sampogna F, Tabolli S, Abeni D. Living with psoriasis: prevalence of shame, anger, worry, and problems in daily activities and social life. Acta Derm Venereol. 2012;92:299–303.PubMedCrossRef
37.
Zurück zum Zitat Janowski K, Steuden S, Pietrzak A, Krasowska D, Kaczmarek L, Gradus I, et al. Social support and adaptation to the disease in men and women with psoriasis. Arch Dermatol Res. 2012;304:421–32.PubMedPubMedCentralCrossRef Janowski K, Steuden S, Pietrzak A, Krasowska D, Kaczmarek L, Gradus I, et al. Social support and adaptation to the disease in men and women with psoriasis. Arch Dermatol Res. 2012;304:421–32.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Chan MF, Chua TL, Goh BK, Aw CW, Thng TG, Lee SM. Investigating factors associated with depression of vitiligo patients in Singapore. J Clin Nurs. 2012;21:1614–21.PubMedCrossRef Chan MF, Chua TL, Goh BK, Aw CW, Thng TG, Lee SM. Investigating factors associated with depression of vitiligo patients in Singapore. J Clin Nurs. 2012;21:1614–21.PubMedCrossRef
39.
Zurück zum Zitat Kwan Z, Bong YB, Tan LL, Lim SX, Yong ASW, Ch'ng CC, et al. Determinants of quality of life and psychological status in adults with psoriasis. Arch Dermatol Res. 2018;310:443–51.PubMedCrossRef Kwan Z, Bong YB, Tan LL, Lim SX, Yong ASW, Ch'ng CC, et al. Determinants of quality of life and psychological status in adults with psoriasis. Arch Dermatol Res. 2018;310:443–51.PubMedCrossRef
40.
Zurück zum Zitat Dieris-Hirche J, Gieler U, Petrak F, Milch W, Te Wildt B, Dieris B, et al. Suicidal ideation in adult patients with atopic dermatitis: A German cross-sectional study. Acta Derm Venereol. 2017;97:1189–95.PubMedCrossRef Dieris-Hirche J, Gieler U, Petrak F, Milch W, Te Wildt B, Dieris B, et al. Suicidal ideation in adult patients with atopic dermatitis: A German cross-sectional study. Acta Derm Venereol. 2017;97:1189–95.PubMedCrossRef
41.
Zurück zum Zitat Premkumar R, Kar B, Rajan P, Richard J. Major precipitating factors for stigma among stigmatized vitiligo and psoriasis patients with brown-black skin shades. Indian J Dermatol Venereol Leprol. 2013;79(5):703–5.PubMedCrossRef Premkumar R, Kar B, Rajan P, Richard J. Major precipitating factors for stigma among stigmatized vitiligo and psoriasis patients with brown-black skin shades. Indian J Dermatol Venereol Leprol. 2013;79(5):703–5.PubMedCrossRef
42.
Zurück zum Zitat Kwan Z, Bong YB, Tan LL, Lim SX, Yong AS, Ch’ng CC, et al. Socioeconomic and sociocultural determinants of psychological distress and quality of life among patients with psoriasis in a selected multi-ethnic Malaysian population. Psychol Health Med. 2017;22:184–95.PubMedCrossRef Kwan Z, Bong YB, Tan LL, Lim SX, Yong AS, Ch’ng CC, et al. Socioeconomic and sociocultural determinants of psychological distress and quality of life among patients with psoriasis in a selected multi-ethnic Malaysian population. Psychol Health Med. 2017;22:184–95.PubMedCrossRef
43.
Zurück zum Zitat Alpsoy E, Polat M, FettahlioGlu-Karaman B, Karadag AS, Kartal-Durmazlar P, YalCın B, et al. Internalized stigma in psoriasis: A multicenter study. J Dermatol. 2017;44:885–91.PubMedCrossRef Alpsoy E, Polat M, FettahlioGlu-Karaman B, Karadag AS, Kartal-Durmazlar P, YalCın B, et al. Internalized stigma in psoriasis: A multicenter study. J Dermatol. 2017;44:885–91.PubMedCrossRef
44.
Zurück zum Zitat Molina-Leyva A, Molina-Leyva I, Almodovar-Real A, Ruiz-Carrascosa JC, Naranjo-Sintes R, Jimenez-Moleon JJ. Prevalence and associated factors of erectile dysfunction in patients with moderate to severe psoriasis and healthy population: A comparative study considering physical and psychological factors. Arch Sex Behav. 2016;45:2047–55.PubMedCrossRef Molina-Leyva A, Molina-Leyva I, Almodovar-Real A, Ruiz-Carrascosa JC, Naranjo-Sintes R, Jimenez-Moleon JJ. Prevalence and associated factors of erectile dysfunction in patients with moderate to severe psoriasis and healthy population: A comparative study considering physical and psychological factors. Arch Sex Behav. 2016;45:2047–55.PubMedCrossRef
45.
Zurück zum Zitat Innamorati M, Quinto RM, Imperatori C, Lora V, Graceffa D, Fabbricatore M, Lester D, Contardi A, Bonifati C. Health-related quality of life and its association with alexithymia and difficulties in emotion regulation in patients with psoriasis. Compr Psychiatry. 2016;70:200–8.PubMedCrossRef Innamorati M, Quinto RM, Imperatori C, Lora V, Graceffa D, Fabbricatore M, Lester D, Contardi A, Bonifati C. Health-related quality of life and its association with alexithymia and difficulties in emotion regulation in patients with psoriasis. Compr Psychiatry. 2016;70:200–8.PubMedCrossRef
46.
Zurück zum Zitat Lee S, Xie L, Wang Y, Vaidya N, Baser O. Evaluating the effect of treatment persistence the economic Burden of moderate to severe psoriasis and/or psoriatic arthritis patients in the U.S. Department of Defense population. J Manag Care Spec Pharm. 2018;24:654–63.PubMed Lee S, Xie L, Wang Y, Vaidya N, Baser O. Evaluating the effect of treatment persistence the economic Burden of moderate to severe psoriasis and/or psoriatic arthritis patients in the U.S. Department of Defense population. J Manag Care Spec Pharm. 2018;24:654–63.PubMed
47.
Zurück zum Zitat Kimball AB, Edson-Heredia E, Zhu B, Guo J, Maeda-Chubachi T, Shen W, Bianchi MT. Understanding the relationship between pruritus severity and work productivity in patients with moderate-to-severe psoriasis: sleep problems are a mediating factor. J Drugs Dermatol. 2016;15(2):183–8.PubMed Kimball AB, Edson-Heredia E, Zhu B, Guo J, Maeda-Chubachi T, Shen W, Bianchi MT. Understanding the relationship between pruritus severity and work productivity in patients with moderate-to-severe psoriasis: sleep problems are a mediating factor. J Drugs Dermatol. 2016;15(2):183–8.PubMed
48.
Zurück zum Zitat Ahmed AE, Al-Dahmash AM, Al-Boqami QT, Al-Tebainawi YF. Depression, anxiety and stress among Saudi Arabian dermatology patients: cross-sectional study. Sultan Qaboos Univ Med J. 2016;16:e217–23.PubMedPubMedCentralCrossRef Ahmed AE, Al-Dahmash AM, Al-Boqami QT, Al-Tebainawi YF. Depression, anxiety and stress among Saudi Arabian dermatology patients: cross-sectional study. Sultan Qaboos Univ Med J. 2016;16:e217–23.PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Khoury LR, Danielsen PL, Skiveren J. Body image altered by psoriasis. A study based on individual interviews and a model for body image. J Dermatolog Treat. 2014;25:2–7.PubMedCrossRef Khoury LR, Danielsen PL, Skiveren J. Body image altered by psoriasis. A study based on individual interviews and a model for body image. J Dermatolog Treat. 2014;25:2–7.PubMedCrossRef
50.
Zurück zum Zitat Lakuta P, Marcinkiewicz K, Bergler-Czop B, Brzezinska-Wcislo L, Slomian A. Associations between site of skin lesions and depression, social anxiety, body-related emotions and feelings of stigmatization in psoriasis patients. Postepy Dermatol Alergol. 2018;35:60–6.PubMedPubMedCentralCrossRef Lakuta P, Marcinkiewicz K, Bergler-Czop B, Brzezinska-Wcislo L, Slomian A. Associations between site of skin lesions and depression, social anxiety, body-related emotions and feelings of stigmatization in psoriasis patients. Postepy Dermatol Alergol. 2018;35:60–6.PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Nayak PB, Girisha BS, Noronha TM. Correlation between disease severity, family income, and quality of life in psoriasis: A study from South India. Indian Dermatol Online J. 2018;9:165–9.PubMedPubMedCentral Nayak PB, Girisha BS, Noronha TM. Correlation between disease severity, family income, and quality of life in psoriasis: A study from South India. Indian Dermatol Online J. 2018;9:165–9.PubMedPubMedCentral
52.
Zurück zum Zitat Hebert AA, Stingl G, Ho LK, Lynde C, Cappelleri JC, Tallman AM, Zielinski MA, Frajzyngier V, Gerber RA. Patient impact and economic burden of mild-to-moderate atopic dermatitis. Curr Med Res Opin. 2018;34(12):2177–85.PubMedCrossRef Hebert AA, Stingl G, Ho LK, Lynde C, Cappelleri JC, Tallman AM, Zielinski MA, Frajzyngier V, Gerber RA. Patient impact and economic burden of mild-to-moderate atopic dermatitis. Curr Med Res Opin. 2018;34(12):2177–85.PubMedCrossRef
53.
54.
Zurück zum Zitat Korman NJ, Zhao Y, Pike J, Roberts J. Relationship between psoriasis severity, clinical symptoms, quality of life and work productivity among patients in the USA. Clin Exp Dermatol. 2016;41:514–21.PubMedCrossRef Korman NJ, Zhao Y, Pike J, Roberts J. Relationship between psoriasis severity, clinical symptoms, quality of life and work productivity among patients in the USA. Clin Exp Dermatol. 2016;41:514–21.PubMedCrossRef
55.
Zurück zum Zitat Tee SI, Lim ZV, Theng CT, Chan KL, Giam YC. A prospective cross-sectional study of anxiety and depression in patients with psoriasis in Singapore. J Eur Acad Dermatol Venereol. 2016;30:1159–64.PubMedCrossRef Tee SI, Lim ZV, Theng CT, Chan KL, Giam YC. A prospective cross-sectional study of anxiety and depression in patients with psoriasis in Singapore. J Eur Acad Dermatol Venereol. 2016;30:1159–64.PubMedCrossRef
56.
Zurück zum Zitat Yano C, Saeki H, Ishiji T, Ishiuji Y, Sato J, Tofuku Y, et al. Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitis. J Dermatol. 2013;40:736–9.PubMedCrossRef Yano C, Saeki H, Ishiji T, Ishiuji Y, Sato J, Tofuku Y, et al. Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitis. J Dermatol. 2013;40:736–9.PubMedCrossRef
57.
Zurück zum Zitat Schneider G, Heuft G, Hockmann J. Determinants of social anxiety and social avoidance in psoriasis outpatients. J Eur Acad Dermatol Venereol. 2013;27:383–6.PubMedCrossRef Schneider G, Heuft G, Hockmann J. Determinants of social anxiety and social avoidance in psoriasis outpatients. J Eur Acad Dermatol Venereol. 2013;27:383–6.PubMedCrossRef
58.
Zurück zum Zitat Geale K, Henriksson M, Schmitt-Egenolf M. How is disease severity associated with quality of life in psoriasis patients? Evidence from a longitudinal population-based study in Sweden. Health Qual Life Outcomes. 2017;15(1):151.PubMedPubMedCentralCrossRef Geale K, Henriksson M, Schmitt-Egenolf M. How is disease severity associated with quality of life in psoriasis patients? Evidence from a longitudinal population-based study in Sweden. Health Qual Life Outcomes. 2017;15(1):151.PubMedPubMedCentralCrossRef
59.
Zurück zum Zitat Korman NJ, Zhao Y, Roberts J, Pike J, Sullivan E, Tsang Y, Karagiannis T. Impact of psoriasis flare and remission on quality of life and work productivity: a real-world study in the USA. Dermatol Online J. 2016;22:7. Korman NJ, Zhao Y, Roberts J, Pike J, Sullivan E, Tsang Y, Karagiannis T. Impact of psoriasis flare and remission on quality of life and work productivity: a real-world study in the USA. Dermatol Online J. 2016;22:7.
60.
Zurück zum Zitat Pereira MG, Brito L, Smith T. Dyadic adjustment, family coping, body image, quality of life and psychological morbidity in patients with psoriasis and their partners. Int J Behav Med. 2012;19(3):260–9.PubMedCrossRef Pereira MG, Brito L, Smith T. Dyadic adjustment, family coping, body image, quality of life and psychological morbidity in patients with psoriasis and their partners. Int J Behav Med. 2012;19(3):260–9.PubMedCrossRef
61.
Zurück zum Zitat Chrostowska-Plak D, Reich A, Szepietowski JC. Relationship between itch and psychological status of patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2013;27:e239–42.PubMedCrossRef Chrostowska-Plak D, Reich A, Szepietowski JC. Relationship between itch and psychological status of patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2013;27:e239–42.PubMedCrossRef
62.
Zurück zum Zitat Lewis-Beck C, Abouzaid S, Xie L, Baser O, Kim E. Analysis of the relationship between psoriasis symptom severity and quality of life, work productivity, and activity impairment among patients with moderate-to-severe psoriasis using structural equation modeling. Patient Prefer Adherence. 2013;7:199–205.PubMedPubMedCentral Lewis-Beck C, Abouzaid S, Xie L, Baser O, Kim E. Analysis of the relationship between psoriasis symptom severity and quality of life, work productivity, and activity impairment among patients with moderate-to-severe psoriasis using structural equation modeling. Patient Prefer Adherence. 2013;7:199–205.PubMedPubMedCentral
63.
Zurück zum Zitat Sarhan D, Mohammed GFA, Gomaa AHA, Eyada MMK. Female genital dialogues: female genital self-image, sexual dysfunction, and quality of life in patients with vitiligo with and without genital affection. J Sex Marital Ther. 2016;42:267–6.PubMedCrossRef Sarhan D, Mohammed GFA, Gomaa AHA, Eyada MMK. Female genital dialogues: female genital self-image, sexual dysfunction, and quality of life in patients with vitiligo with and without genital affection. J Sex Marital Ther. 2016;42:267–6.PubMedCrossRef
64.
Zurück zum Zitat Molina-Leyva A, Almodovar-Real A, Ruiz-Carrascosa JC, Naranjo-Sintes R, Serrano-Ortega S, Jimenez-Moleon JJ. Distribution pattern of psoriasis affects sexual function in moderate to severe psoriasis: A prospective case series study. J Sex Med. 2014;11:2882–9.PubMedCrossRef Molina-Leyva A, Almodovar-Real A, Ruiz-Carrascosa JC, Naranjo-Sintes R, Serrano-Ortega S, Jimenez-Moleon JJ. Distribution pattern of psoriasis affects sexual function in moderate to severe psoriasis: A prospective case series study. J Sex Med. 2014;11:2882–9.PubMedCrossRef
65.
Zurück zum Zitat Ji S, Zang Z, Ma H, et al. Erectile dysfunction in patients with plaque psoriasis: the relation of depression and cardiovascular factors. Int J Impot Res. 2016;28:96–100.PubMedCrossRef Ji S, Zang Z, Ma H, et al. Erectile dysfunction in patients with plaque psoriasis: the relation of depression and cardiovascular factors. Int J Impot Res. 2016;28:96–100.PubMedCrossRef
66.
Zurück zum Zitat Ahmed A, Shah R, Papadopoulos L, Bewley A. An ethnographic study into the psychological impact and adaptive mechanisms of living with hand eczema. Clin Exp Dermatol. 2015;40:495–501.PubMedCrossRef Ahmed A, Shah R, Papadopoulos L, Bewley A. An ethnographic study into the psychological impact and adaptive mechanisms of living with hand eczema. Clin Exp Dermatol. 2015;40:495–501.PubMedCrossRef
67.
Zurück zum Zitat Brito L, da Graça Pereira M. Individual and family variables in psoriasis: A study with patients and partners. Psicologia: Teoria e Pesquisa. 2012;28:171–9. Brito L, da Graça Pereira M. Individual and family variables in psoriasis: A study with patients and partners. Psicologia: Teoria e Pesquisa. 2012;28:171–9.
68.
Zurück zum Zitat Koo J, Marangell LB, Nakamura M, Armstrong A, Jeon C, Bhutani T, et al. Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression. J Eur Acad Dermatol Venereol. 2017;31:1999–2009.PubMedCrossRef Koo J, Marangell LB, Nakamura M, Armstrong A, Jeon C, Bhutani T, et al. Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression. J Eur Acad Dermatol Venereol. 2017;31:1999–2009.PubMedCrossRef
69.
Zurück zum Zitat Egeberg A, Khalid U, Gislason GH, Mallbris L, Skov L, Hansen PR. Impact of depression on risk of myocardial infarction, stroke and cardiovascular death in patients with psoriasis: A Danish Nationwide study. Acta Derm Venereol. 2016;96:218–21.PubMedCrossRef Egeberg A, Khalid U, Gislason GH, Mallbris L, Skov L, Hansen PR. Impact of depression on risk of myocardial infarction, stroke and cardiovascular death in patients with psoriasis: A Danish Nationwide study. Acta Derm Venereol. 2016;96:218–21.PubMedCrossRef
70.
Zurück zum Zitat Zhu B, Cao C. Correlative research between stigma, social support and quality of life in patients with psoriasis. Chin Nurs Res. 2016;30:3639–42. Zhu B, Cao C. Correlative research between stigma, social support and quality of life in patients with psoriasis. Chin Nurs Res. 2016;30:3639–42.
71.
Zurück zum Zitat Pichaimuthu R, Ramaswamy P, Bikash K, Joseph R. A measurement of the stigma among vitiligo and psoriasis patients in India. Indian J Dermatol Venereol Leprol. 2011;77:300–6.PubMedCrossRef Pichaimuthu R, Ramaswamy P, Bikash K, Joseph R. A measurement of the stigma among vitiligo and psoriasis patients in India. Indian J Dermatol Venereol Leprol. 2011;77:300–6.PubMedCrossRef
72.
Zurück zum Zitat Norreslet LB, Ebbehoj NE, Ellekilde Bonde JP, Thomsen SF, Agner T. The impact of atopic dermatitis on work life - a systematic review. J Eur Acad Dermatol Venereol. 2018;32:23–38.PubMedCrossRef Norreslet LB, Ebbehoj NE, Ellekilde Bonde JP, Thomsen SF, Agner T. The impact of atopic dermatitis on work life - a systematic review. J Eur Acad Dermatol Venereol. 2018;32:23–38.PubMedCrossRef
74.
Zurück zum Zitat Cazzaniga S, Ballmer-Weber BK, Grani N, Spring P, Bircher A, Anliker M, et al. Medical, psychological and socio-economic implications of chronic hand eczema: a cross-sectional study. J Eur Acad Dermatol Venereol. 2016;30:628–37.PubMedCrossRef Cazzaniga S, Ballmer-Weber BK, Grani N, Spring P, Bircher A, Anliker M, et al. Medical, psychological and socio-economic implications of chronic hand eczema: a cross-sectional study. J Eur Acad Dermatol Venereol. 2016;30:628–37.PubMedCrossRef
75.
Zurück zum Zitat Mattila K, Leino M, Mustonen A, Koulu L, Tuominen R. Influence of psoriasis on work. Eur J Dermatol. 2013;23(2):208–11.PubMed Mattila K, Leino M, Mustonen A, Koulu L, Tuominen R. Influence of psoriasis on work. Eur J Dermatol. 2013;23(2):208–11.PubMed
76.
Zurück zum Zitat Levy AR, Davie AM, Brazier NC, et al. Economic burden of moderate to severe plaque psoriasis in Canada. Int J Dermatol. 2012;51:1432–40.PubMedCrossRef Levy AR, Davie AM, Brazier NC, et al. Economic burden of moderate to severe plaque psoriasis in Canada. Int J Dermatol. 2012;51:1432–40.PubMedCrossRef
77.
Zurück zum Zitat Itakura A, Tani Y, Kaneko N, Hide M. Impact of chronic urticaria on quality of life and work in Japan: results of a real-world study. J Dermatol. 2018;45:963–70.PubMedPubMedCentralCrossRef Itakura A, Tani Y, Kaneko N, Hide M. Impact of chronic urticaria on quality of life and work in Japan: results of a real-world study. J Dermatol. 2018;45:963–70.PubMedPubMedCentralCrossRef
78.
Zurück zum Zitat Schmitt J, Küster D. Correlation between dermatology life quality index (DLQI) scores and work limitations questionnaire (WLQ) allows the calculation of percent work productivity loss in patients with psoriasis. Arch Dermatol Res. 2015;307(5):451–3.PubMedCrossRef Schmitt J, Küster D. Correlation between dermatology life quality index (DLQI) scores and work limitations questionnaire (WLQ) allows the calculation of percent work productivity loss in patients with psoriasis. Arch Dermatol Res. 2015;307(5):451–3.PubMedCrossRef
79.
Zurück zum Zitat Nguyen CM, Beroukhim K, Danesh MJ, Babikian A, Koo J, Leon A. The psychosocial impact of acne, vitiligo, and psoriasis: a review. Clin Cosmet Investig Dermatol. 2016;9:383–92.PubMedPubMedCentralCrossRef Nguyen CM, Beroukhim K, Danesh MJ, Babikian A, Koo J, Leon A. The psychosocial impact of acne, vitiligo, and psoriasis: a review. Clin Cosmet Investig Dermatol. 2016;9:383–92.PubMedPubMedCentralCrossRef
80.
Zurück zum Zitat Rzepecki AK, McLellan BN, Elbuluk N. Beyond traditional treatment: the importance of psychosocial therapy in Vitiligo. J Drugs Dermatol. 2018;17(6):688–91.PubMed Rzepecki AK, McLellan BN, Elbuluk N. Beyond traditional treatment: the importance of psychosocial therapy in Vitiligo. J Drugs Dermatol. 2018;17(6):688–91.PubMed
81.
Zurück zum Zitat Paul D, Kinsella L, Walsh O, Sweenry C, Timoney I, Lynch M, et al. Mindfulness-based interventions for psoriasis: A randomized controlled trial. Mindfulness. 2018;10(2):288–300. Paul D, Kinsella L, Walsh O, Sweenry C, Timoney I, Lynch M, et al. Mindfulness-based interventions for psoriasis: A randomized controlled trial. Mindfulness. 2018;10(2):288–300.
82.
Zurück zum Zitat Hashimoto K, Ogawa Y, Takeshima N, Furukawa TA. Psychological and educational interventions for atopic dermatitis in adults: A systematic review and meta-analysis. Behav Chang. 2017;34:48–65.CrossRef Hashimoto K, Ogawa Y, Takeshima N, Furukawa TA. Psychological and educational interventions for atopic dermatitis in adults: A systematic review and meta-analysis. Behav Chang. 2017;34:48–65.CrossRef
83.
Zurück zum Zitat Van Beugen S, Ferwerda M, Spillekom-van Koulil S, Smit JV, Zeeuwen-Franssen ME, Kroft EB, et al. Tailored therapist-guided internet-based cognitive behavioral treatment for psoriasis: A randomized controlled trial. Psychother Psychosom. 2016;85:297–307.PubMedCrossRef Van Beugen S, Ferwerda M, Spillekom-van Koulil S, Smit JV, Zeeuwen-Franssen ME, Kroft EB, et al. Tailored therapist-guided internet-based cognitive behavioral treatment for psoriasis: A randomized controlled trial. Psychother Psychosom. 2016;85:297–307.PubMedCrossRef
84.
Zurück zum Zitat Shah R, Hunt J, Webb TL, Thompson AR. Starting to develop self-help for social anxiety associated with vitiligo: using clinical significance to measure the potential effectiveness of enhanced psychological self-help. Br J Dermatol. 2014;171:332–7.PubMedCrossRef Shah R, Hunt J, Webb TL, Thompson AR. Starting to develop self-help for social anxiety associated with vitiligo: using clinical significance to measure the potential effectiveness of enhanced psychological self-help. Br J Dermatol. 2014;171:332–7.PubMedCrossRef
85.
Zurück zum Zitat Bundy C, Pinder B, Bucci S, Reeves D, Griffiths CE, Tarrier N. A novel, web-based, psychological intervention for people with psoriasis: the electronic targeted intervention for psoriasis (eTIPs) study. Br J Dermatol. 2013;169:329–36.PubMedCrossRef Bundy C, Pinder B, Bucci S, Reeves D, Griffiths CE, Tarrier N. A novel, web-based, psychological intervention for people with psoriasis: the electronic targeted intervention for psoriasis (eTIPs) study. Br J Dermatol. 2013;169:329–36.PubMedCrossRef
86.
Zurück zum Zitat Zill JM, Christalle E, Tillenburg N, Mrowietz U, Augustin M, Härter M, Dirmaier J. Effects of psychosocial interventions on patient-reported outcomes in patients with psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2018. Zill JM, Christalle E, Tillenburg N, Mrowietz U, Augustin M, Härter M, Dirmaier J. Effects of psychosocial interventions on patient-reported outcomes in patients with psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2018.
87.
Zurück zum Zitat Nagarajan P, Thappa DM. Effect of an educational and psychological intervention on knowledge and quality of life among patients with psoriasis. Indian Dermatol Online J. 2018;9(1):27–32.PubMedPubMedCentral Nagarajan P, Thappa DM. Effect of an educational and psychological intervention on knowledge and quality of life among patients with psoriasis. Indian Dermatol Online J. 2018;9(1):27–32.PubMedPubMedCentral
88.
Zurück zum Zitat Heratizadeh A, Werfel T, Wollenberg A, Abraham S, Plank-Habibi S, Schnopp C, et al. Effects of structured patient education in adults with atopic dermatitis: multicenter randomized controlled trial. J Allergy Clin Immunol. 2017;140:845–53.PubMedCrossRef Heratizadeh A, Werfel T, Wollenberg A, Abraham S, Plank-Habibi S, Schnopp C, et al. Effects of structured patient education in adults with atopic dermatitis: multicenter randomized controlled trial. J Allergy Clin Immunol. 2017;140:845–53.PubMedCrossRef
89.
Zurück zum Zitat Jha A, Mehta M, Khaitan BK, Sharma VK, Ramam M. Cognitive behavior therapy for psychosocial stress in vitiligo. Indian J Dermatol Venereol Leprol. 2016;82(3):308–10.PubMedCrossRef Jha A, Mehta M, Khaitan BK, Sharma VK, Ramam M. Cognitive behavior therapy for psychosocial stress in vitiligo. Indian J Dermatol Venereol Leprol. 2016;82(3):308–10.PubMedCrossRef
90.
Zurück zum Zitat Keyworth C, Nelson PA, Bundy C, Pye SR, Griffiths CEM, Cordingley L. Does message framing affect changes in behavioural intentions in people with psoriasis? A randomized exploratory study examining health risk communication. Psychol Health Med. 2018;23:763–78.PubMedCrossRef Keyworth C, Nelson PA, Bundy C, Pye SR, Griffiths CEM, Cordingley L. Does message framing affect changes in behavioural intentions in people with psoriasis? A randomized exploratory study examining health risk communication. Psychol Health Med. 2018;23:763–78.PubMedCrossRef
91.
Zurück zum Zitat Ahmed A, Steed L, Burden-Teh E, Shah R, Sanyal S, Tour S, Dowey S, Whitton M, Batchelor JM, Bewley AP. Identifying key components for a psychological intervention for people with vitiligo - a quantitative and qualitative study in the United Kingdom using web-based questionnaires of people with vitiligo and healthcare professionals. J Eur Acad Dermatol Venereol. 2018;32:2275–83.PubMedCrossRef Ahmed A, Steed L, Burden-Teh E, Shah R, Sanyal S, Tour S, Dowey S, Whitton M, Batchelor JM, Bewley AP. Identifying key components for a psychological intervention for people with vitiligo - a quantitative and qualitative study in the United Kingdom using web-based questionnaires of people with vitiligo and healthcare professionals. J Eur Acad Dermatol Venereol. 2018;32:2275–83.PubMedCrossRef
92.
Zurück zum Zitat Ormerod E, Bale T, Stone N. Psoriasis direct service: an audit and review. Dermatol Nurs. 2017;16(1):45–9. Ormerod E, Bale T, Stone N. Psoriasis direct service: an audit and review. Dermatol Nurs. 2017;16(1):45–9.
93.
Zurück zum Zitat Gionfriddo MR, Pulk RA, Sahni DR, Vijayanagar SG, Chronowski JJ, Jones LK, et al. ProvenCare-psoriasis: A disease management model to optimize care. Dermatol Online J. 2018;24:3. Gionfriddo MR, Pulk RA, Sahni DR, Vijayanagar SG, Chronowski JJ, Jones LK, et al. ProvenCare-psoriasis: A disease management model to optimize care. Dermatol Online J. 2018;24:3.
Metadaten
Titel
The psychosocial adaptation of patients with skin disease: a scoping review
verfasst von
Xiu-jie Zhang
Ai-ping Wang
Tie-ying Shi
Jun Zhang
Hui Xu
Da-qiu Wang
Li Feng
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
BMC Public Health / Ausgabe 1/2019
Elektronische ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-019-7775-0

Weitere Artikel der Ausgabe 1/2019

BMC Public Health 1/2019 Zur Ausgabe